Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Conexeu Sciences Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Jeffrey Sharpe (filed 2026-09-15).
Who is behind it
Conexeu Sciences Inc.: incorporated in Nevada; business address in Reno, Nevada; industry Orthopedic, Prosthetic & Surgical Appliances & Supplies (Form D, 2026-09-29).
Officers and directors, each with the role and the filing that names them:
- DAVID R BOGART: Executive Officer, Director (Form D, 2026-09-29)
- MILES HARRISON: Executive Officer, Director (Form D, 2026-09-29)
- AARON FARBERG: Director (Form D, 2026-09-29)
- STEPHEN D INOUYE: Executive Officer (Form D, 2026-09-29)
- CLAUDIA CHAVEZ-MUNOZ: Executive Officer (Form D, 2026-09-29)
- JEFF SHARPE: Director (Form D, 2026-09-29)
- Z PAUL LORENC: Director (Form D, 2026-09-29)
- SEBASTIAN PURCELL: Director (Form D, 2026-09-29)
- BRIAN PILCHER: Executive Officer (Form D, 2026-09-29)
- ANDREW COSTA: Director (Form D, 2026-09-29)
- APRIL BURKE: Director (Form D, 2026-09-29)
- ANA BASTIANI-POSNER: Director (Form D, 2026-09-29)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-09-15 | Jeffrey Sharpe | 5.2% |
| Schedule 13G, 2026-09-04 | Multi-Valor Aif Umbrella Fund Sicav Quintus Growth Fund | 9.99% |
| Schedule 13G/A, 2026-09-04 | Multi-Valor Aif Umbrella Fund Sicav Quintus Growth Fund | 9.99% |
| Schedule 13D, 2026-08-18 | Jeffrey Sharpe | 5.4% |
| Schedule 13G, 2026-08-18 | David Bogart | 8.1% |
| Schedule 13G, 2026-08-14 | Onepointtwo Capital Ventures LLC | 6.8% |
| Schedule 13G, 2026-08-14 | Onepointtwo Capital Ventures Ii LLC | 5.5% |
| Schedule 13G, 2026-08-14 | Purcell Lynn Sebastian | 12.3% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-09-29 | $31K | $31K |
| Form D, 2026-09-15 | $252K | $252K |
| Form D, 2026-08-31 | $89K | $89K |
| Form D, 2026-07-31 | $63K | $63K |
| Form D, 2026-06-30 | $86K | $86K |
| Form D, 2026-06-30 | $203 | $466K |
| Form D, 2026-06-10 | $23K | $137K |
| Form D, 2026-05-21 | $45K | $45K |
Latest IPO step: Conexeu Sciences Inc. filed its final IPO prospectus, ticker CNXU (424B4, 2026-05-11).
IPO filings: 424B4, 2026-05-11, S-1/A, 2026-04-17, S-1/A, 2026-04-10, S-1/A, 2026-04-06, S-1/A, 2026-03-26; ticker CNXU on Nasdaq.
Related pages
Funding and filing history5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/conexeu-sciences-incLast updated 2026-10-18
Primary record: Schedule 13D/A, 2026-09-15 · Form D, 2026-09-29 · 424B4, 2026-05-11 · S-1/A, 2026-04-17
Who owns Conexeu Sciences Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/conexeu-sciences-inc